Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Li J, Wang M, Zhang X, Wang X, Yang X, Bao S, Liu W, Li J, Yuan Q, Quan F, Chen W, Wan L, Huangfu H, Qiao F, Wei S, Zhou Y, Xu Z, Ren X, Shi H, Wang Y, Zhao Y, Song D, Yang H, Zhang P, Cui Q, Li Q, Feng Y, Zhu H, Han L, Wang M, Zhu K, Li Y, Guo Q, Du DY, Wang C, Zhang Y, Zhang L

Open source

DOI: 10.1016/j.lanwpc.2026.101969
Published: 2026 Sep
Container: The Lancet regional health. Western Pacific
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanwpc.2026.101969,
  title = {Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.},
  author = {Li J and Wang M and Zhang X and Wang X and Yang X and Bao S and Liu W and Li J and Yuan Q and Quan F and Chen W and Wan L and Huangfu H and Qiao F and Wei S and Zhou Y and Xu Z and Ren X and Shi H and Wang Y and Zhao Y and Song D and Yang H and Zhang P and Cui Q and Li Q and Feng Y and Zhu H and Han L and Wang M and Zhu K and Li Y and Guo Q and Du DY and Wang C and Zhang Y and Zhang L},
  year = {2026},
  journal = {The Lancet regional health. Western Pacific},
  doi = {10.1016/j.lanwpc.2026.101969},
  url = {https://doi.org/10.1016/j.lanwpc.2026.101969}
}

RIS

TY  - JOUR
TI  - Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
AU  - Li J
AU  - Wang M
AU  - Zhang X
AU  - Wang X
AU  - Yang X
AU  - Bao S
AU  - Liu W
AU  - Li J
AU  - Yuan Q
AU  - Quan F
AU  - Chen W
AU  - Wan L
AU  - Huangfu H
AU  - Qiao F
AU  - Wei S
AU  - Zhou Y
AU  - Xu Z
AU  - Ren X
AU  - Shi H
AU  - Wang Y
AU  - Zhao Y
AU  - Song D
AU  - Yang H
AU  - Zhang P
AU  - Cui Q
AU  - Li Q
AU  - Feng Y
AU  - Zhu H
AU  - Han L
AU  - Wang M
AU  - Zhu K
AU  - Li Y
AU  - Guo Q
AU  - Du DY
AU  - Wang C
AU  - Zhang Y
AU  - Zhang L
PY  - 2026
JO  - The Lancet regional health. Western Pacific
DO  - 10.1016/j.lanwpc.2026.101969
UR  - https://doi.org/10.1016/j.lanwpc.2026.101969
ER  -

APA

J, L., M, W., X, Z., X, W., X, Y., S, B., W, L., J, L., Q, Y., F, Q., W, C., L, W., H, H., F, Q., S, W., Y, Z., Z, X., X, R., H, S., Y, W., Y, Z., D, S., H, Y., P, Z., Q, C., Q, L., Y, F., H, Z., L, H., M, W., K, Z., Y, L., Q, G., DY, D., C, W., Y, Z., & L, Z. (2026). Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.. The Lancet regional health. Western Pacific. https://doi.org/10.1016/j.lanwpc.2026.101969

Source records

pubmed · retrieved 2026-09-26T21:20:47.903Z